PURPOSE: Development of new treatments is critical to effective protection against radiation-induced injury. We investigate the potential of developing small-molecule inhibitors of glycogen synthase kinase 3beta (GSK-3beta)-SB216763 or SB415286-as radioprotective agents to attenuate intestinal injury. METHODS AND MATERIALS: A survival study was done by use of C57BL/6J mice to evaluate the radioprotective effect of GSK-3beta inhibitors. Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay and immunohistochemical staining for Bax and Bcl-2 were used to assess apoptosis in the small intestines of the treated mice. A clonogenic survival study, apoptosis assays (staining with annexin V or 4',6-diamidino-2-phenylindole), and immunoblot analysis of beta-catenin, Bcl-2, Bax, and caspase 3 were done by use of Rat intestinal epithelial cell line IEC-6 cells. RESULTS: Pretreatment with SB415286 significantly improved survival of mice irradiated with 8 and 12 Gy. Mice pretreated with SB216763 or SB415286 showed a significant reduction in TUNEL- and Bax-positive cells and an increase in Bcl-2-positive cells in intestinal crypts at 4 and/or 12 h after radiation with 4 and/or 8 Gy compared with radiation alone. Pretreatment of irradiated IEC-6 cells with GSK-3beta inhibitors significantly increased clonogenic survival compared with cells treated with radiation alone. This increase was due to the attenuation of radiation-induced apoptosis, as shown by annexin V and 4',6-diamidino-2-phenylindole assays, as well as immunoblot analysis of Bcl-2, Bax, and caspase 3. CONCLUSIONS: Glycogen synthase kinase 3beta small-molecule inhibitors protect mouse intestine from radiation-induced damage in cell culture and in vivo and improve survival of mice. Molecular mechanisms of this protection involve attenuated radiation-induced apoptosis regulated by Bcl-2, Bax, and caspase 3. Therefore GSK-3beta inhibitors reduce deleterious consequences of intestinal irradiation and thereby improve quality of life during radiation therapy. Copyright 2010 Elsevier Inc. All rights reserved.
PURPOSE: Development of new treatments is critical to effective protection against radiation-induced injury. We investigate the potential of developing small-molecule inhibitors of glycogen synthase kinase 3beta (GSK-3beta)-SB216763 or SB415286-as radioprotective agents to attenuate intestinal injury. METHODS AND MATERIALS: A survival study was done by use of C57BL/6J mice to evaluate the radioprotective effect of GSK-3beta inhibitors. Terminal deoxynucleotidyl transferase dUTP nick end labelling (TUNEL) assay and immunohistochemical staining for Bax and Bcl-2 were used to assess apoptosis in the small intestines of the treated mice. A clonogenic survival study, apoptosis assays (staining with annexin V or 4',6-diamidino-2-phenylindole), and immunoblot analysis of beta-catenin, Bcl-2, Bax, and caspase 3 were done by use of Rat intestinal epithelial cell line IEC-6 cells. RESULTS: Pretreatment with SB415286 significantly improved survival of mice irradiated with 8 and 12 Gy. Mice pretreated with SB216763 or SB415286 showed a significant reduction in TUNEL- and Bax-positive cells and an increase in Bcl-2-positive cells in intestinal crypts at 4 and/or 12 h after radiation with 4 and/or 8 Gy compared with radiation alone. Pretreatment of irradiated IEC-6 cells with GSK-3beta inhibitors significantly increased clonogenic survival compared with cells treated with radiation alone. This increase was due to the attenuation of radiation-induced apoptosis, as shown by annexin V and 4',6-diamidino-2-phenylindole assays, as well as immunoblot analysis of Bcl-2, Bax, and caspase 3. CONCLUSIONS:Glycogen synthase kinase 3beta small-molecule inhibitors protect mouse intestine from radiation-induced damage in cell culture and in vivo and improve survival of mice. Molecular mechanisms of this protection involve attenuated radiation-induced apoptosis regulated by Bcl-2, Bax, and caspase 3. Therefore GSK-3beta inhibitors reduce deleterious consequences of intestinal irradiation and thereby improve quality of life during radiation therapy. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: F Paris; Z Fuks; A Kang; P Capodieci; G Juan; D Ehleiter; A Haimovitz-Friedman; C Cordon-Cardo; R Kolesnick Journal: Science Date: 2001-07-13 Impact factor: 47.728
Authors: Piyajit Watcharasit; Gautam N Bijur; Jaroslaw W Zmijewski; Ling Song; Anna Zmijewska; Xinbin Chen; Gail V W Johnson; Richard S Jope Journal: Proc Natl Acad Sci U S A Date: 2002-06-04 Impact factor: 11.205
Authors: M P Coghlan; A A Culbert; D A Cross; S L Corcoran; J W Yates; N J Pearce; O L Rausch; G J Murphy; P S Carter; L Roxbee Cox; D Mills; M J Brown; D Haigh; R W Ward; D G Smith; K J Murray; A D Reith; J C Holder Journal: Chem Biol Date: 2000-10
Authors: Jamie K Waselenko; Thomas J MacVittie; William F Blakely; Nicki Pesik; Albert L Wiley; William E Dickerson; Horace Tsu; Dennis L Confer; C Norman Coleman; Thomas Seed; Patrick Lowry; James O Armitage; Nicholas Dainiak Journal: Ann Intern Med Date: 2004-06-15 Impact factor: 25.391
Authors: Elena A Komarova; Roman V Kondratov; Kaihua Wang; Konstantin Christov; Tatiana V Golovkina; John R Goldblum; Andrei V Gudkov Journal: Oncogene Date: 2004-04-22 Impact factor: 9.867
Authors: Joseph F Sanchez; Lynn F Sniderhan; Andrea L Williamson; Shongshan Fan; Shikha Chakraborty-Sett; Sanjay B Maggirwar Journal: Mol Cell Biol Date: 2003-07 Impact factor: 4.272
Authors: Vitali Alexeev; Elizabeth Lash; April Aguillard; Laura Corsini; Avi Bitterman; Keith Ward; Adam P Dicker; Alban Linnenbach; Ulrich Rodeck Journal: Mol Cancer Ther Date: 2014-11-14 Impact factor: 6.261
Authors: Bo Hai; Zhenhua Yang; Lei Shangguan; Yanqiu Zhao; Arthur Boyer; Fei Liu Journal: Int J Radiat Oncol Biol Phys Date: 2012-02-16 Impact factor: 7.038
Authors: Céline Charvet; Manuela Wissler; Prisca Brauns-Schubert; Shang-Jui Wang; Yi Tang; Florian C Sigloch; Hestia Mellert; Martin Brandenburg; Silke E Lindner; Bernhard Breit; Douglas R Green; Steven B McMahon; Christoph Borner; Wei Gu; Ulrich Maurer Journal: Mol Cell Date: 2011-06-10 Impact factor: 17.970
Authors: Xiaoyu Jiang; Carlos J Perez-Torres; Dinesh Thotala; John A Engelbach; Liya Yuan; Jeremy Cates; Feng Gao; Robert E Drzymala; Keith M Rich; Robert E Schmidt; Joseph J H Ackerman; Dennis E Hallahan; Joel R Garbow Journal: Int J Radiat Oncol Biol Phys Date: 2014-07-15 Impact factor: 7.038